Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Technical advance

Assessing the agreement of biomarker data in the presence of left-censoring

Authors: Uthumporn Domthong, Chirag R Parikh, Paul L Kimmel, Vernon M Chinchilli, the Assessment, Serial Evaluation, and Subsequent Sequelae of Acute Kidney Injury (ASSESS-AKI) Consortium

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

In many clinical biomarker studies, Lin’s concordance correlation coefficient (CCC) is commonly used to assess the level of agreement of a biomarker measured under two different conditions. However, measurement of a specific biomarker typically cannot provide accurate numerical values below the lower limit of detection (LLD) of the assay, which results in left-censored data. Most researchers discard the data below the LLD or apply simple data imputation methods in the presence of left-censored data, such as replacing values below the LLD with a fixed number less than or equal to the LLD. This is not statistically optimal, because it often leads to biased estimates and overestimates the precision.

Methods

We describe a simple method using a bivariate normal distribution in this situation and apply SAS statistical software to arrive at the maximum likelihood (ML) estimate of the parameters and construct the estimate of the CCC. We conduct a computer simulation study to investigate the statistical properties of the ML method versus the data deletion and simple data imputation method. We also contrast the methods with real data using two urine biomarkers, Interleukin 18 and Cystatin C.

Results

The computer simulation studies confirm that the ML procedure is superior to the data deletion and simple data imputation procedures. In all of the simulated scenarios, the ML method yields the smallest relative bias and the highest percentage of the 95% confidence intervals that include the true value of the CCC. In the first simulation scenario (sample size of 100 paired data points, 25% left-censoring for both members of the pair, true CCC of 0.238), the relative bias is −1.43% for the ML method, −40.97% for the data deletion method, and it ranges between −12.94% and −21.72% for the simple data imputation methods. Similarly, when the left-censoring for one of the members of the data pairs increases from 25% to 40%, the relative bias displays the same pattern for all methods.

Conclusions

When estimating the CCC from paired biomarker data in the presence of left-censored values, the ML method works better than data deletion and simple data imputation methods.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hornung RW, Reed LD: Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg. 1990, 5: 46-51. 10.1080/1047322X.1990.10389587.CrossRef Hornung RW, Reed LD: Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg. 1990, 5: 46-51. 10.1080/1047322X.1990.10389587.CrossRef
2.
go back to reference Lyles RH, Williams JK, Chuachoowong R: Correlating two viral load assays with known detection limits. Biometrics. 2001, 57: 1238-1244. 10.1111/j.0006-341X.2001.01238.x.CrossRefPubMed Lyles RH, Williams JK, Chuachoowong R: Correlating two viral load assays with known detection limits. Biometrics. 2001, 57: 1238-1244. 10.1111/j.0006-341X.2001.01238.x.CrossRefPubMed
3.
go back to reference Barnhart HX, Song J, Lyles RH: Assay validation for left-censored data. Stat Med. 2005, 24: 3347-3360. 10.1002/sim.2225.CrossRefPubMed Barnhart HX, Song J, Lyles RH: Assay validation for left-censored data. Stat Med. 2005, 24: 3347-3360. 10.1002/sim.2225.CrossRefPubMed
4.
go back to reference Parikh CR, Butrymowicz I, Yu A, Chinchilli VM, Park M, Hsu C, Reeves WB, Devarajan P, Kimmel PL, Siew ED, Liu KD: Urine stability studies for novel biomarkers of acute kidney injury. Am J Kidney Dis. 2013, 63: 567-572.CrossRefPubMedPubMedCentral Parikh CR, Butrymowicz I, Yu A, Chinchilli VM, Park M, Hsu C, Reeves WB, Devarajan P, Kimmel PL, Siew ED, Liu KD: Urine stability studies for novel biomarkers of acute kidney injury. Am J Kidney Dis. 2013, 63: 567-572.CrossRefPubMedPubMedCentral
5.
go back to reference Patterson SD, Aebersold RH: Proteomics: the first decade and beyond. Nat Genet. 2003, 33: 311-323. 10.1038/ng1106.CrossRefPubMed Patterson SD, Aebersold RH: Proteomics: the first decade and beyond. Nat Genet. 2003, 33: 311-323. 10.1038/ng1106.CrossRefPubMed
6.
go back to reference Lin LI: A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989, 45: 255-268. 10.2307/2532051.CrossRefPubMed Lin LI: A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989, 45: 255-268. 10.2307/2532051.CrossRefPubMed
Metadata
Title
Assessing the agreement of biomarker data in the presence of left-censoring
Authors
Uthumporn Domthong
Chirag R Parikh
Paul L Kimmel
Vernon M Chinchilli
the Assessment, Serial Evaluation, and Subsequent Sequelae of Acute Kidney Injury (ASSESS-AKI) Consortium
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-144

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.